Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference By: Medpace Holdings, Inc. via Business Wire August 30, 2021 at 16:05 PM EDT Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Baird’s Global Healthcare Conference Date: Tuesday, September 14, 2021 Presentation: 8:30 a.m. ET Speakers: Jesse Geiger, President, and Kevin Brady, Chief Financial Officer A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event. About Medpace Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries as of June 30, 2021. View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005516/en/Contacts Investor Contact: Lauren Morris 513.579.9911 x11994 l.morris@medpace.com Media Contact: Julie Hopkins 513.579.9911 x12627 j.hopkins@medpace.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference By: Medpace Holdings, Inc. via Business Wire August 30, 2021 at 16:05 PM EDT Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Baird’s Global Healthcare Conference Date: Tuesday, September 14, 2021 Presentation: 8:30 a.m. ET Speakers: Jesse Geiger, President, and Kevin Brady, Chief Financial Officer A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event. About Medpace Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries as of June 30, 2021. View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005516/en/Contacts Investor Contact: Lauren Morris 513.579.9911 x11994 l.morris@medpace.com Media Contact: Julie Hopkins 513.579.9911 x12627 j.hopkins@medpace.com
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference: Baird’s Global Healthcare Conference Date: Tuesday, September 14, 2021 Presentation: 8:30 a.m. ET Speakers: Jesse Geiger, President, and Kevin Brady, Chief Financial Officer A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event. About Medpace Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries as of June 30, 2021. View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005516/en/
Investor Contact: Lauren Morris 513.579.9911 x11994 l.morris@medpace.com Media Contact: Julie Hopkins 513.579.9911 x12627 j.hopkins@medpace.com
